<!DOCTYPE html>
<html>
<head>
	<title>MRCG Clinical Guidelines</title>
	<meta name="viewport" content="width=device-width, initial-scale=1.0, minimum-scale=1.0, maximum-scale=2.0, user-scalable=1">
  
	<<meta name=Generator content="Microsoft Word 14 (filtered)">
	<link rel="stylesheet" href="jquery.mobile-1.4.5.min.css" />
	<script src="jquery-1.11.1.min.js"></script>
	<script src="jquery.mobile-1.4.5.min.js"></script>
	<script type="text/javascript" src="cordova.js"></script>      
	<style>
	.show {display: block;}
  .tablist-left {
    width: 25%;
    display: inline-block;
  }
  .tablist-content {
    width: 60%;
    display: inline-block;
    vertical-align: top;
    margin-left: 5%;
    }
    body {
  font-family: Arial, Helvetica, sans-serif;
  font-size: 20px;
}
.footer-button-left,
.footer-button-right {
    position: absolute;
    margin: 0;
    top: auto;
    bottom: 0.24em;
}
.footer-button-left {
    left: 0.4em;
}
.footer-button-right {
    right: 0.4em;
}
<!--
 /* Font Definitions */
 @font-face
	{font-family:Wingdings;
	panose-1:5 0 0 0 0 0 0 0 0 0;}
@font-face
	{font-family:"MS Mincho";
	panose-1:2 2 6 9 4 2 5 8 3 4;}
@font-face
	{font-family:"Angsana New";
	panose-1:2 2 6 3 5 4 5 2 3 4;}
@font-face
	{font-family:"Angsana New";
	panose-1:2 2 6 3 5 4 5 2 3 4;}
@font-face
	{font-family:Tahoma;
	panose-1:2 11 6 4 3 5 4 4 2 4;}
@font-face
	{font-family:"Lucida Grande";}
@font-face
	{font-family:"\@MS Mincho";
	panose-1:2 2 6 9 4 2 5 8 3 4;}
 /* Style Definitions */
 p.MsoNormal, li.MsoNormal, div.MsoNormal
	{margin-top:0cm;
	margin-right:0cm;
	margin-bottom:6.0pt;
	margin-left:0cm;
	font-size:11.0pt;
	font-family:"Arial","sans-serif";}
h1
	{mso-style-link:"Heading 1 Char";
	margin-top:0cm;
	margin-right:0cm;
	margin-bottom:18.0pt;
	margin-left:0cm;
	font-size:14.0pt;
	font-family:"Arial","sans-serif";}
h2
	{mso-style-link:"Heading 2 Char";
	margin-top:6.0pt;
	margin-right:0cm;
	margin-bottom:12.0pt;
	margin-left:0cm;
	font-size:12.0pt;
	font-family:"Arial","sans-serif";}
h3
	{mso-style-link:"Heading 3 Char";
	margin-top:6.0pt;
	margin-right:0cm;
	margin-bottom:9.0pt;
	margin-left:0cm;
	font-size:11.0pt;
	font-family:"Arial","sans-serif";
	text-decoration:underline;}
h4
	{mso-style-link:"Heading 4 Char";
	margin-top:2.0pt;
	margin-right:0cm;
	margin-bottom:0cm;
	margin-left:0cm;
	margin-bottom:.0001pt;
	page-break-after:avoid;
	font-size:11.0pt;
	font-family:"Calibri","sans-serif";
	color:#365F91;
	font-weight:normal;
	font-style:italic;}
p.MsoHeader, li.MsoHeader, div.MsoHeader
	{mso-style-link:"Header Char";
	margin:0cm;
	margin-bottom:.0001pt;
	font-size:10.0pt;
	font-family:"Arial","sans-serif";}
p.MsoFooter, li.MsoFooter, div.MsoFooter
	{mso-style-link:"Footer Char";
	margin:0cm;
	margin-bottom:.0001pt;
	font-size:10.0pt;
	font-family:"Arial","sans-serif";}
p.MsoBodyTextIndent3, li.MsoBodyTextIndent3, div.MsoBodyTextIndent3
	{mso-style-link:"Body Text Indent 3 Char";
	margin-top:0cm;
	margin-right:0cm;
	margin-bottom:6.0pt;
	margin-left:14.15pt;
	font-size:11.0pt;
	font-family:"Arial","sans-serif";}
a:link, span.MsoHyperlink
	{color:blue;
	text-decoration:underline;}
a:visited, span.MsoHyperlinkFollowed
	{color:purple;
	text-decoration:underline;}
p.MsoAcetate, li.MsoAcetate, div.MsoAcetate
	{mso-style-link:"Balloon Text Char";
	margin-top:0cm;
	margin-right:0cm;
	margin-bottom:6.0pt;
	margin-left:0cm;
	font-size:9.0pt;
	font-family:"Lucida Grande","sans-serif";}
p.MsoListParagraph, li.MsoListParagraph, div.MsoListParagraph
	{margin-top:0cm;
	margin-right:0cm;
	margin-bottom:6.0pt;
	margin-left:36.0pt;
	font-size:11.0pt;
	font-family:"Arial","sans-serif";}
p.MsoListParagraphCxSpFirst, li.MsoListParagraphCxSpFirst, div.MsoListParagraphCxSpFirst
	{margin-top:0cm;
	margin-right:0cm;
	margin-bottom:0cm;
	margin-left:36.0pt;
	margin-bottom:.0001pt;
	font-size:11.0pt;
	font-family:"Arial","sans-serif";}
p.MsoListParagraphCxSpMiddle, li.MsoListParagraphCxSpMiddle, div.MsoListParagraphCxSpMiddle
	{margin-top:0cm;
	margin-right:0cm;
	margin-bottom:0cm;
	margin-left:36.0pt;
	margin-bottom:.0001pt;
	font-size:11.0pt;
	font-family:"Arial","sans-serif";}
p.MsoListParagraphCxSpLast, li.MsoListParagraphCxSpLast, div.MsoListParagraphCxSpLast
	{margin-top:0cm;
	margin-right:0cm;
	margin-bottom:6.0pt;
	margin-left:36.0pt;
	font-size:11.0pt;
	font-family:"Arial","sans-serif";}
span.Heading1Char
	{mso-style-name:"Heading 1 Char";
	mso-style-link:"Heading 1";
	font-family:"Arial","sans-serif";
	font-weight:bold;}
span.Heading2Char
	{mso-style-name:"Heading 2 Char";
	mso-style-link:"Heading 2";
	font-family:"Arial","sans-serif";
	font-weight:bold;}
span.BalloonTextChar
	{mso-style-name:"Balloon Text Char";
	mso-style-link:"Balloon Text";
	font-family:"Lucida Grande","sans-serif";}
span.Heading3Char
	{mso-style-name:"Heading 3 Char";
	mso-style-link:"Heading 3";
	font-family:"Arial","sans-serif";
	font-weight:bold;
	text-decoration:underline;}
span.HeaderChar
	{mso-style-name:"Header Char";
	mso-style-link:Header;}
span.FooterChar
	{mso-style-name:"Footer Char";
	mso-style-link:Footer;}
span.BodyTextIndent3Char
	{mso-style-name:"Body Text Indent 3 Char";
	mso-style-link:"Body Text Indent 3";
	font-family:"Arial","sans-serif";}
span.Heading4Char
	{mso-style-name:"Heading 4 Char";
	mso-style-link:"Heading 4";
	font-family:"Calibri","sans-serif";
	color:#365F91;
	font-style:italic;}
span.UnresolvedMention
	{mso-style-name:"Unresolved Mention";
	color:#605E5C;
	background:#E1DFDD;}
.MsoChpDefault
	{font-size:10.0pt;
	font-family:"Tahoma","sans-serif";}
 /* Page Definitions */
 @page WordSection1
	{size:612.0pt 792.0pt;
	margin:72.0pt 90.0pt 72.0pt 90.0pt;}
div.WordSection1
	{page:WordSection1;}
 /* List Definitions */
 ol
	{margin-bottom:0cm;}
ul
	{margin-bottom:0cm;}
-->
   .tableCont {
    overflow: auto;
    -webkit-overflow-scrolling: touch;
}
  </style>
  	  	<script>
		$(function(){
			$( "[data-role='header'], [data-role='footer']" ).toolbar();
			$('input[data-type="search"]').val("");			
		});
		// When the user scrolls down 20px from the top of the document, show the button
		window.onscroll = function() {scrollFunction()};
		function scrollFunction() {
		  if (document.body.scrollTop > 20 || document.documentElement.scrollTop > 20) {
			document.getElementById("myBtn").style.display = "block";
		  } else {
			document.getElementById("myBtn").style.display = "none";
		  }
		}
		// When the user clicks on the button, scroll to the top of the document
		function topFunction() {
		  document.body.scrollTop = 0; // For Safari
		  document.documentElement.scrollTop = 0; // For Chrome, Firefox, IE and Opera
		}
	</script>

</head>
<body lang=EN-GB link=blue vlink=purple>
	<div data-role="header" data-tap-toggle="false" data-id="persistent-header" data-position="fixed" data-theme="a">
		<h2 style="font-size:0.75em;"><br><br><br>MRCG<br>Clinical Guidelines</h2>
		<a data-rel="back" class="ui-btn ui-corner-all ui-btn-inline ui-mini header-button-left ui-btn-icon-left ui-icon-carat-l">Back</a>
		<a href="#leftpanel1" class="ui-btn ui-shadow ui-corner-all ui-btn-inline ui-mini header-button-left ui-icon-info ui-btn-icon-notext">About this app</a>
		<a href="#popupNested"  data-rel="popup" class="ui-btn ui-corner-all ui-shadow ui-btn-inline ui-icon-bars ui-btn-icon-right ui-btn-b header-button-right" data-transition="pop">Choose a guideline...</a>
		<div data-role="popup" id="popupNested" data-theme="a"><ul data-role="listview" data-filter="true"data-filter-placeholder="Type to search names..." data-inset="true">
			<li><a href="Acute_kidney_injury_MeG-CLS-071.html">Acute kidney injury</a></li>
			<li><a href="Acute_rheumatic_fever__MeG-CLS-048.html">Acute rheumatic fever </a></li>
			<li><a href="Animal_bites_MeG-CLS-049.html">Animal bites</a></li>
			<li><a href="Asthma_MeG-CLS-001.html">Asthma</a></li>
			<li><a href="Bone_and_joint_infections_guidelines_MeG-CLS-050.html">Bone and joint infections guidelines</a></li>
			<li><a href="Cellulitis_MeG-CLS-051.html">Cellulitis</a></li>
			<li><a href="Chest_pain_and_Acute_Coronary_Syndrome_MeG-CLS-052.html">Chest pain and Acute Coronary Syndrome</a></li>
			<li><a href="Chronic_kidney_disease_MeG-CLS-053.html">Chronic kidney disease</a></li>
			<li><a href="Congenital_heart_disease_MeG-CLS-039.html">Congenital heart disease</a></li>
			<li><a href="Constipation_MeG-CLS-003.html">Constipation</a></li>
			<li><a href="COPD_MeG-CLS-032.html">Chronic Obstructive Pulmonary Disease</a></li>
			<li><a href="Croup_MeG-CLS-059.html">Croup</a></li>
			<li><a href="Deep_venous_thombosis_and_pulmonary_embolism_MeG-CLS-055.html">Deep venous thombosis and pulmonary embolism</a></li>
			<li><a href="Depression_MeG-CLS-075.html">Depression</a></li>
			<li><a href="Developmental_delay_MeG-CLS-054.html">Developmental delay</a></li>
			<li><a href="Diabetes_Mellitus_MeG-CLS-004.html">Diabetes Mellitus</a></li>
			<li><a href="DKA_MeG-CLS-021.html">Diabetic ketoacidosis</a></li>
			<li><a href="Dyspepsia_MeG-CLS-034.html">Dyspepsia</a></li>
			<li><a href="Ear_pain_MeG-CLS-070.html">Ear pain</a></li>
			<li><a href="Epiglottitis_MeG-CLS-063.html">Epiglottitis</a></li>
			<li><a href="Epilepsy_MeG-CLS-056.html">Epilepsy</a></li>
			<li><a href="Fungal_Skin_Infections_MeG-CLS-057.html">Fungal Skin Infections</a></li>
			<li><a href="Gastroenteritis_MeG-CLS-033.html">Gastroenteritis</a></li>
			<li><a href="General_Body_Pain_MeG-CLS-007.html">General Body Pain</a></li>
			<li><a href="Headache_MeG-CLS-045.html">Headache</a></li>
			<li><a href="Heart_failure_adults_MeG-CLS-040.html">Heart failure adults</a></li>
			<li><a href="HHS_MeG-CLS-046.html">Hyperosmolar Hyperglycaemic State</a></li>
			<li><a href="HIV_MeG-CLS-035.html">HIV</a></li>
			<li><a href="Hypertension_MeG-CLS-010.html">Hypertension</a></li>
			<li><a href="Hyperthyroidism_and_goitre_MeG-CLS-027.html">Hyperthyroidism and goitre</a></li>
			<li><a href="Hypocalcaemia_and_hypercalcaemia_MeG-CLS-074.html">Hypocalcaemia and hypercalcaemia</a></li>
			<li><a href="Hypokalaemia_hyperkalaemia_hypermagnesaemia_MeG-CLS-073.html">Hypokalaemia, hyperkalaemia, hypermagnesaemia</a></li>
			<li><a href="Hyponatraemia_and_hypernatraemia_MeG-CLS-072.html">Hyponatraemia and hypernatraemia</a></li>
			<li><a href="Hypothyroidism_MeG-CLS-036.html">Hypothyroidism</a></li>
			<li><a href="Infective_Endocarditis_MeG-CLS-058.html">Infective Endocarditis</a></li>
			<li><a href="Inflammatory_arthritis_and_connective_tissue_disease_MeG-CLS-041.html">Inflammatory arthritis and connective tissue disease</a></li>
			<li><a href="Intestinal_helminths_MeG-CLS-009.html">Intestinal helminths</a></li>
			<li><a href="Liver_disease_MeG-CLS-031.html">Liver disease</a></li>
			<li><a href="Lower_back_pain_MeG-CLS-022.html">Lower back pain</a></li>
			<li><a href="LRI_MeG-CLS-011.html">Lower Respiratory Infections</a></li>
			<li><a href="Malaria_MeG-CLS-012.html">Malaria</a></li>
			<li><a href="Malnutrition_MeG-CLS-037.html">Malnutrition</a></li>
			<li><a href="Meningitis_MeG-CLS-028.html">Meningitis</a></li>
			<li><a href="Neonatal_jaundice_MeG-CLS-060.html">Neonatal jaundice</a></li>
			<li><a href="Nephrotic_Syndrome_MeG-CLS-061.html">Nephrotic Syndrome</a></li>
			<li><a href="Osteoarthritis_MeG-CLS-042.html">Osteoarthritis</a></li>
			<li><a href="Otitis_media_MeG-CLS-023.html">Otitis media</a></li>
			<li><a href="Palliative_Care_MeG-CLS-064.html">Palliative Care</a></li>
			<li><a href="Rectal_prolapse_MeG-CLS-015.html">Rectal prolapse</a></li>
			<li><a href="Rheumatic_heart_disease_MeG-CLS-065.html">Rheumatic heart disease</a></li>
			<li><a href="Scabies_MeG-CLS-066.html">Scabies</a></li>
			<li><a href="Sepsis_in_adults_MeG-CLS-043.html">Sepsis in adults</a></li>
			<li><a href="Sinusitis_MeG-CLS-062.html">Sinusitis</a></li>
			<li><a href="Stevens-Johnsons_syndrome_MeG-CLS-067.html">Stevens-Johnsons syndrome</a></li>
			<li><a href="STI_MeG-CLS-038.html">Sexually Transmitted Infections</a></li>
			<li><a href="Stroke_MeG-CLS-020.html">Stroke</a></li>
			<li><a href="TB_MeG-CLS-044.html">TB</a></li>
			<li><a href="Tonsillitis_and_pharyngitis_MeG-CLS-024.html">Tonsillitis and pharyngitis</a></li>
			<li><a href="Trauma_MeG-CLS-068.html">Trauma</a></li>
			<li><a href="Upper_respiratory_tract_infections_MeG-CLS-018.html">Upper respiratory tract infections</a></li>
			<li><a href="UTI_MeG-CLS-019.html">Urinary tract infections</a></li>
</ul>
	  </div>
	  </div>
	 
    </div><!-- /header -->
<div data-role="page">
	<div role="main" class="ui-content">
<div class=WordSection1>
<h1><span lang=EN-US>Liver disease</span></h1>
<h2><i><span lang=EN-US>Executive summary</span></i></h2>
<h2><span lang=EN-US>Introduction</span></h2>
<p class=MsoNormal><span lang=EN-US>The liver is responsible for many critical
functions within the body and should it become diseased or injured, the loss of
those functions can cause significant damage to the body. Liver disease is a
broad term that covers all the potential problems that cause the liver to fail
to perform its designated functions. Usually, more than 75% or three quarters
of liver tissue needs to be affected before a decrease in function occurs.</span></p>
<p class=MsoNormal><span lang=EN-US>Management of these patients is divided
into the assessment and treatment of patients with a new diagnosis of liver
disease and that of those with established chronic liver disease (CLD) who have
decompensated. </span></p>
<h2><span lang=EN-US>Target User</span></h2>
<p class=MsoListParagraphCxSpFirst style='text-indent:-18.0pt'><span
lang=EN-US style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-US>Doctors</span></p>
<p class=MsoListParagraphCxSpLast style='text-indent:-18.0pt'><span lang=EN-US
style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-US>Nurses</span></p>
<h2><span lang=EN-US>Target area of use </span></h2>
<p class=MsoListParagraph style='text-indent:-18.0pt'><span lang=EN-US
style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-US>Ward</span></p>
<h2><span lang=EN-US>Key areas of focus/new additions/changes</span></h2>
<p class=MsoNormal><span lang=EN-US>This guideline outlines the initial
diagnosis of liver disease in our setting as well as the management of patients
with established disease who decompensate.</span></p>
<h2><span lang=EN-US>Limitations</span></h2>
<p class=MsoNormal><span lang=EN-US>We have limited access to most of the
diagnostic tests for causes of liver disease. </span></p>
<p class=MsoNormal><span lang=EN-US>Access to higher level care is largely not
available – except for dialysis, which might be possible at the teaching
hospital.</span></p>
<span lang=EN-US style='font-size:11.0pt;font-family:"Arial","sans-serif"'><br
clear=all style='page-break-before:always'>
</span>
<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt'><b><span
lang=EN-US style='font-size:12.0pt'>&nbsp;</span></b></p>
<h2><span lang=EN-US>Presenting symptoms and signs</span></h2>
<p class=MsoNormal><span lang=EN-US>If the patient is in extremis, they should
be resuscitated prior to any other intervention – the most likely causes are an
acute GI bleed or bacterial septicaemia.</span></p>
<p class=MsoNormal><span lang=EN-US>Patients with liver disease can present
with many different symptoms including: </span></p>
<p class=MsoListParagraphCxSpFirst style='margin-bottom:0cm;margin-bottom:.0001pt;
text-indent:-18.0pt'><span lang=EN-US style='font-family:Symbol'>·<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-US>Weakness and fatigue</span></p>
<p class=MsoListParagraphCxSpMiddle style='margin-bottom:0cm;margin-bottom:
.0001pt;text-indent:-18.0pt'><span lang=EN-US style='font-family:Symbol'>·<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-US>Jaundice</span></p>
<p class=MsoListParagraphCxSpMiddle style='margin-bottom:0cm;margin-bottom:
.0001pt;text-indent:-18.0pt'><span lang=EN-US style='font-family:Symbol'>·<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-US>Nausea</span></p>
<p class=MsoListParagraphCxSpMiddle style='margin-bottom:0cm;margin-bottom:
.0001pt;text-indent:-18.0pt'><span lang=EN-US style='font-family:Symbol'>·<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-US>Vomiting</span></p>
<p class=MsoListParagraphCxSpMiddle style='margin-bottom:0cm;margin-bottom:
.0001pt;text-indent:-18.0pt'><span lang=EN-US style='font-family:Symbol'>·<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-US>Weight loss</span></p>
<p class=MsoListParagraphCxSpMiddle style='margin-bottom:0cm;margin-bottom:
.0001pt;text-indent:-18.0pt'><span lang=EN-US style='font-family:Symbol'>·<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-US>Right upper quadrant pain</span></p>
<p class=MsoListParagraphCxSpMiddle style='margin-bottom:0cm;margin-bottom:
.0001pt;text-indent:-18.0pt'><span lang=EN-US style='font-family:Symbol'>·<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-US>Confusion</span></p>
<p class=MsoListParagraphCxSpMiddle style='margin-bottom:0cm;margin-bottom:
.0001pt;text-indent:-18.0pt'><span lang=EN-US style='font-family:Symbol'>·<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-US>Reduced GCS</span></p>
<p class=MsoListParagraphCxSpMiddle style='margin-bottom:0cm;margin-bottom:
.0001pt;text-indent:-18.0pt'><span lang=EN-US style='font-family:Symbol'>·<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-US>Clubbing</span></p>
<p class=MsoListParagraphCxSpLast style='text-indent:-18.0pt'><span lang=EN-US
style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-US>Hematemesis.</span></p>
<p class=MsoNormal><span lang=EN-US>They may present with signs of anaemia,
sepsis, acute liver disease or chronic liver disease.</span></p>
<p class=MsoNormal><span lang=EN-US>The patient’s background history must be
taken in order to establish the cause of the underlying liver disease. This may
affect the treatment given.</span></p>
<p class=MsoNormal><span lang=EN-US>The history of the current event must also
be taken with particular note of any gastrointestinal bleeding, change in girth
size, pain, confusion, difficulty breathing, increase in jaundice, recent
medications and traditional treatments taken.</span></p>
<h2><span lang=EN-US>Examination findings</span></h2>
<p class=MsoListParagraphCxSpFirst style='text-indent:-18.0pt'><span lang=EN
style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN>General findings: anaemia, fever, tachycardia,
altered level of consciousness or confusion, peripheral oedema.</span></p>
<p class=MsoListParagraphCxSpMiddle style='text-indent:-18.0pt'><span lang=EN
style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN>Signs of chronic liver disease: liver flap,
clubbing, palmar erythema, bruising, spider naevi, gynaecomastia, testicular
atrophy, ascites, venous collaterals.</span></p>
<p class=MsoListParagraphCxSpMiddle style='text-indent:-18.0pt'><span lang=EN
style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN>Liver: small in cirrhosis, large in acute hepatitis
or neoplasm.</span></p>
<p class=MsoListParagraphCxSpMiddle style='text-indent:-18.0pt'><span lang=EN
style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN>Splenomegaly: suggests portal hypertension.</span></p>
<p class=MsoListParagraphCxSpMiddle style='text-indent:-18.0pt'><span lang=EN
style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN>PR: this is essential if there is any suggestion of
a GI bleed.</span></p>
<p class=MsoListParagraphCxSpMiddle style='text-indent:-18.0pt'><span lang=EN
style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN>Signs of excess alcohol – Dupuytren’s contracture –
parotid enlargement.</span></p>
<p class=MsoListParagraphCxSpLast style='text-indent:-18.0pt'><span lang=EN
style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN>Stigmata of HIV: Oral thrush, Herpes Zoster scar.</span></p>
<h2><span lang=EN-US>Investigations</span></h2>
<p class=MsoNormal><span lang=EN-US>Tests which may be appropriate to assess
patient’s current condition include:</span></p>
<p class=MsoListParagraphCxSpFirst style='text-indent:-18.0pt'><span
lang=EN-US style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-US>FBC, LFTs, albumin, INR, U&amp;Es, blood glucose</span></p>
<p class=MsoListParagraphCxSpMiddle style='text-indent:-18.0pt'><span
lang=EN-US style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-US>Urinary dipstick</span></p>
<p class=MsoListParagraphCxSpMiddle style='text-indent:-18.0pt'><span
lang=EN-US style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-US>Blood cultures and chest X-ray</span></p>
<p class=MsoListParagraphCxSpLast style='text-indent:-18.0pt'><span lang=EN-US
style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-US>Ascitic tap (if ascites is present this is
essential) – send for MC&amp;S, albumin, AFBs.</span></p>
<p class=MsoNormal><span lang=EN-US>Note that FBC, INR, U&amp;Es, LFTs and
ascitic tap microscopy and albumin are all urgent tests and <b><i>the results
should be reviewed within 4 hours of admission</i></b> to the ward in any
acutely unwell patient. </span></p>
<p class=MsoNormal><span lang=EN-US>Tests to identify possible causes include:</span></p>
<p class=MsoListParagraphCxSpFirst style='text-indent:-18.0pt'><span
lang=EN-US style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-US>Viral serology: HIV, HBsAg (HCV, HAV when available)</span></p>
<p class=MsoListParagraphCxSpMiddle style='text-indent:-18.0pt'><span
lang=EN-US style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-US>Hb genotype</span></p>
<p class=MsoListParagraphCxSpMiddle style='text-indent:-18.0pt'><span
lang=EN-US style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-US>Ultrasound – for jaundiced patients ask directly
about duct dilatation.</span></p>
<p class=MsoListParagraphCxSpLast style='text-indent:-18.0pt'><span lang=EN-US
style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-US>Consider autoantibodies, ferritin and AFP when
available. </span></p>
<h2><span lang=EN-US>Causes of decompensation in CLD</span></h2>
<p class=MsoNormal><span lang=EN-US>For patients with chronic liver disease,
management will depend on the cause of the decompensation. </span><span
lang=EN-US>Patients with CLD may decompensate because of a complication of
their underlying liver disease or because of a second insult to the liver or
their overall system.</span></p>
<p class=MsoNormal><span lang=EN-US>Complications of CLD are:</span></p>
<p class=MsoListParagraphCxSpFirst style='text-indent:-18.0pt'><span
lang=EN-US style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-US>Variceal haemorrhage</span></p>
<p class=MsoListParagraphCxSpMiddle style='text-indent:-18.0pt'><span
lang=EN-US style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-US>Portal vein thrombosis</span></p>
<p class=MsoListParagraphCxSpMiddle style='text-indent:-18.0pt'><span
lang=EN-US style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-US>Ascites</span></p>
<p class=MsoListParagraphCxSpMiddle style='text-indent:-18.0pt'><span
lang=EN-US style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-US>Spontaneous bacterial peritonitis</span></p>
<p class=MsoListParagraphCxSpMiddle style='text-indent:-18.0pt'><span
lang=EN-US style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-US>Hepatic encephalopathy</span></p>
<p class=MsoListParagraphCxSpMiddle style='text-indent:-18.0pt'><span
lang=EN-US style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-US>Hepatorenal syndrome</span></p>
<p class=MsoListParagraphCxSpMiddle style='text-indent:-18.0pt'><span
lang=EN-US style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-US>Hepatopulmonary syndrome</span></p>
<p class=MsoListParagraphCxSpLast style='text-indent:-18.0pt'><span lang=EN-US
style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-US>Hepatocellular carcinoma</span></p>
<p class=MsoNormal><span lang=EN-US>Common causes of a second insult are:</span></p>
<p class=MsoListParagraphCxSpFirst style='text-indent:-18.0pt'><span
lang=EN-US style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-US>Acute viral hepatitis</span></p>
<p class=MsoListParagraphCxSpMiddle style='text-indent:-18.0pt'><span
lang=EN-US style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-US>Drug-induced liver injury (which may be caused
by traditional treatment as well as prescribed medications)</span></p>
<p class=MsoListParagraphCxSpLast style='text-indent:-18.0pt'><span lang=EN-US
style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-US>Bacterial infection (UTI, LRI etc)</span></p>
<span lang=EN-US style='font-size:11.0pt;font-family:"Arial","sans-serif"'><br
clear=all style='page-break-before:always'>
</span>
<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt'><b><span
lang=EN-US style='font-size:12.0pt'>&nbsp;</span></b></p>
<h2><span lang=EN-US>Management</span></h2>
<h3><span lang=EN-US>Newly diagnosed liver disease</span></h3>
<p class=MsoNormal><span lang=EN-US>Treat precipitants and possible causes.</span></p>
<p class=MsoNormal><span lang=EN-US>Ensure adequate hydration and nutrition
(give e-pap if there is any doubt). </span></p>
<p class=MsoNormal><span lang=EN-US>Avoid hepatotoxic drugs. </span></p>
<p class=MsoNormal><span lang=EN-US>Manage according to particular
complications (hepatic encephalopathy is common). </span></p>
<p class=MsoNormal><span lang=EN-US>Seek specialist support if acute liver
disease is suspected. </span></p>
<h3><span lang=EN-US>All patients with CLD</span></h3>
<p class=MsoNormal><span lang=EN-US>All patients admitted with CLD should have
their Child-Pugh score calculated in order to provide prognostic information.</span></p>
<p class=MsoNormal><span lang=EN-US>Use the table below to assign a score for
each item:</span></p>
<div class="tableCont">
  <table class=MsoNormalTable border=1 cellspacing=0 cellpadding=0
 style='border-collapse:collapse;border:none'>
 <tr>
  <td width=101 valign=top style='width:75.4pt;border:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal><b><span lang=EN-US style='font-size:10.0pt'>Points</span></b></p>
  </td>
  <td width=101 valign=top style='width:75.4pt;border:solid windowtext 1.0pt;
  border-left:none;padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal><b><span lang=EN-US style='font-size:10.0pt'>1</span></b></p>
  </td>
  <td width=101 valign=top style='width:75.4pt;border:solid windowtext 1.0pt;
  border-left:none;padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal><b><span lang=EN-US style='font-size:10.0pt'>2</span></b></p>
  </td>
  <td width=101 valign=top style='width:75.4pt;border:solid windowtext 1.0pt;
  border-left:none;padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal><b><span lang=EN-US style='font-size:10.0pt'>3</span></b></p>
  </td>
 </tr>
 <tr>
  <td width=101 valign=top style='width:75.4pt;border:solid windowtext 1.0pt;
  border-top:none;padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal><span lang=EN-US style='font-size:10.0pt'>Ascites</span></p>
  </td>
  <td width=101 valign=top style='width:75.4pt;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal><span lang=EN-US style='font-size:10.0pt'>None</span></p>
  </td>
  <td width=101 valign=top style='width:75.4pt;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal><span lang=EN-US style='font-size:10.0pt'>Slight</span></p>
  </td>
  <td width=101 valign=top style='width:75.4pt;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal><span lang=EN-US style='font-size:10.0pt'>Moderate or
  above</span></p>
  </td>
 </tr>
 <tr>
  <td width=101 valign=top style='width:75.4pt;border:solid windowtext 1.0pt;
  border-top:none;padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal><span lang=EN-US style='font-size:10.0pt'>Bilirubin</span></p>
  </td>
  <td width=101 valign=top style='width:75.4pt;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal><span lang=EN-US style='font-size:10.0pt'>&lt;34.2</span></p>
  </td>
  <td width=101 valign=top style='width:75.4pt;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal><span lang=EN-US style='font-size:10.0pt'>34.2-51.3</span></p>
  </td>
  <td width=101 valign=top style='width:75.4pt;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal><span lang=EN-US style='font-size:10.0pt'>&gt;51.3</span></p>
  </td>
 </tr>
 <tr>
  <td width=101 valign=top style='width:75.4pt;border:solid windowtext 1.0pt;
  border-top:none;padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal><span lang=EN-US style='font-size:10.0pt'>Serum albumin</span></p>
  </td>
  <td width=101 valign=top style='width:75.4pt;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal><span lang=EN-US style='font-size:10.0pt'>&gt;35</span></p>
  </td>
  <td width=101 valign=top style='width:75.4pt;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal><span lang=EN-US style='font-size:10.0pt'>28-35</span></p>
  </td>
  <td width=101 valign=top style='width:75.4pt;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal><span lang=EN-US style='font-size:10.0pt'>&lt;28</span></p>
  </td>
 </tr>
 <tr>
  <td width=101 valign=top style='width:75.4pt;border:solid windowtext 1.0pt;
  border-top:none;padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal><span lang=EN-US style='font-size:10.0pt'>INR</span></p>
  </td>
  <td width=101 valign=top style='width:75.4pt;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal><span lang=EN-US style='font-size:10.0pt'>&lt;1.7</span></p>
  </td>
  <td width=101 valign=top style='width:75.4pt;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal><span lang=EN-US style='font-size:10.0pt'>1.7-2.3</span></p>
  </td>
  <td width=101 valign=top style='width:75.4pt;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal><span lang=EN-US style='font-size:10.0pt'>&gt;2.3</span></p>
  </td>
 </tr>
 <tr>
  <td width=101 valign=top style='width:75.4pt;border:solid windowtext 1.0pt;
  border-top:none;padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal><span lang=EN-US style='font-size:10.0pt'>Encephalopathy</span></p>
  </td>
  <td width=101 valign=top style='width:75.4pt;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal><span lang=EN-US style='font-size:10.0pt'>None</span></p>
  </td>
  <td width=101 valign=top style='width:75.4pt;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal><span lang=EN-US style='font-size:10.0pt'>Grade 1-2</span></p>
  </td>
  <td width=101 valign=top style='width:75.4pt;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal><span lang=EN-US style='font-size:10.0pt'>Grade 3-4</span></p>
  </td>
 </tr>
</table>
</div>
<p class=MsoNormal><span lang=EN-US>&nbsp;</span></p>
<p class=MsoNormal><span lang=EN-US>Add the score and interpret the findings
according to this table:</span></p>
<div class="tableCont">
  <table class=MsoNormalTable border=1 cellspacing=0 cellpadding=0
 style='border-collapse:collapse;border:none'>
 <tr>
  <td width=101 valign=top style='width:75.4pt;border:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal><b><span lang=EN-US style='font-size:10.0pt'>Class</span></b></p>
  </td>
  <td width=101 valign=top style='width:75.4pt;border:solid windowtext 1.0pt;
  border-left:none;padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal><b><span lang=EN-US style='font-size:10.0pt'>Score</span></b></p>
  </td>
  <td width=101 valign=top style='width:75.4pt;border:solid windowtext 1.0pt;
  border-left:none;padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal><b><span lang=EN-US style='font-size:10.0pt'>1 year
  survival rate</span></b></p>
  </td>
  <td width=101 valign=top style='width:75.4pt;border:solid windowtext 1.0pt;
  border-left:none;padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal><b><span lang=EN-US style='font-size:10.0pt'>2 year
  survival rate</span></b></p>
  </td>
 </tr>
 <tr>
  <td width=101 valign=top style='width:75.4pt;border:solid windowtext 1.0pt;
  border-top:none;padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal><span lang=EN-US style='font-size:10.0pt'>A</span></p>
  </td>
  <td width=101 valign=top style='width:75.4pt;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal><span lang=EN-US style='font-size:10.0pt'>5-6</span></p>
  </td>
  <td width=101 valign=top style='width:75.4pt;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal><span lang=EN-US style='font-size:10.0pt'>100%</span></p>
  </td>
  <td width=101 valign=top style='width:75.4pt;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal><span lang=EN-US style='font-size:10.0pt'>85%</span></p>
  </td>
 </tr>
 <tr>
  <td width=101 valign=top style='width:75.4pt;border:solid windowtext 1.0pt;
  border-top:none;padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal><span lang=EN-US style='font-size:10.0pt'>B</span></p>
  </td>
  <td width=101 valign=top style='width:75.4pt;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal><span lang=EN-US style='font-size:10.0pt'>7-9</span></p>
  </td>
  <td width=101 valign=top style='width:75.4pt;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal><span lang=EN-US style='font-size:10.0pt'>80%</span></p>
  </td>
  <td width=101 valign=top style='width:75.4pt;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal><span lang=EN-US style='font-size:10.0pt'>60%</span></p>
  </td>
 </tr>
 <tr>
  <td width=101 valign=top style='width:75.4pt;border:solid windowtext 1.0pt;
  border-top:none;padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal><span lang=EN-US style='font-size:10.0pt'>C</span></p>
  </td>
  <td width=101 valign=top style='width:75.4pt;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal><span lang=EN-US style='font-size:10.0pt'>10-15</span></p>
  </td>
  <td width=101 valign=top style='width:75.4pt;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal><span lang=EN-US style='font-size:10.0pt'>45%</span></p>
  </td>
  <td width=101 valign=top style='width:75.4pt;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal><span lang=EN-US style='font-size:10.0pt'>35%</span></p>
  </td>
 </tr>
</table>
</div>
<p class=MsoNormal><span lang=EN-US>&nbsp;</span></p>
<p class=MsoNormal><span lang=EN-US>In the rare cases where the patient can
control a cause of deterioration (especially alcoholic liver disease), if they
remove this risk factor (i.e. stop drinking) they can improve their prognosis
significantly.</span></p>
<p class=MsoNormal><span lang=EN-US>If the INR is greater than 3.5, then
vitamin K should be prescribed. In most cases, 10 mg OD orally for 3 days is
adequate.</span></p>
<h3 style='margin-bottom:6.0pt'><span lang=EN-US>Variceal haemorrhage</span></h3>
<p class=MsoNormal><span lang=EN-US>This should be suspected whenever there is
GI bleeding. It may present with either haematemesis or melaena.</span></p>
<p class=MsoNormal><span lang=EN-US>Other causes of GI haemorrhage are
possible, but are less serious. Only 50% of bleeding varices will stop bleeding
spontaneously. The outlook is even worse for patients with Child-Pugh Class C
disease.</span></p>
<p class=MsoNormal><span lang=EN-US>Re-bleeding is also very common and is more
likely for older patients, those with encephalopathy, ascites, renal failure,
alcoholic liver disease or low platelets.</span></p>
<p class=MsoNormal><span lang=EN-US>Management begins with urgent fluid
resuscitation including the siting of 2 large bore cannulas, iv normal saline
to restore BP and urgent cross-matching of blood. Whole blood should be
transfused as soon as possible aiming for an Hb of 9 g/dl.</span></p>
<p class=MsoNormal><span lang=EN-US>Endoscopy should be arranged if available. </span></p>
<p class=MsoListParagraphCxSpFirst style='text-indent:-18.0pt'><span
lang=EN-US style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-US>Unstable patients with severe acute upper GI
bleeding should be scoped as soon as possible after resuscitation.</span></p>
<p class=MsoListParagraphCxSpMiddle style='text-indent:-18.0pt'><span
lang=EN-US style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-US>Stable patients with upper GI bleeding should be
scoped within the next working day after admission. </span></p>
<p class=MsoListParagraphCxSpLast style='text-indent:-18.0pt'><span lang=EN-US
style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-US>Any varices should be banded. If another cause
of bleeding is identified, management should be altered to reflect this. </span></p>
<p class=MsoNormal><span lang=EN-US>None of the vasoactive medications shown to
be effective in controlling acute bleeding are available here. </span></p>
<p class=MsoNormal><span lang=EN-US>Patients are at high risk of concomitant
infection and the presence of infection increases the risk of re-bleeding so
all patients should be given prophylactic antibiotics – usually ciprofloxacin
500 mg BD for 7 days.</span></p>
<p class=MsoNormal><span lang=EN-US>Patients are at high risk of encephalopathy
and should be treated with lactulose if they are not passing stool at least
twice each day – 20 ml TDS to start.</span></p>
<p class=MsoNormal><i><span lang=EN-US>Secondary prophylaxis </span></i></p>
<p class=MsoNormal><span lang=EN-US>This should be offered to all patients who
have had a variceal bleed.</span></p>
<p class=MsoNormal><span lang=EN-US>Both non-cardioselective beta blockers and
variceal band ligation should be given. </span></p>
<p class=MsoNormal><span lang=EN-US>Give propranolol 40 mg BD and titrate up
the dose until the HR is 50-55 bpm. The maximum dose is 320 mg per day. This
should also be given to patients identified as having varices who have not yet
had a bleed (primary prophylaxis).</span></p>
<h3 style='margin-bottom:6.0pt'><span lang=EN-US>Spontaneous bacterial
peritonitis (SBP)</span></h3>
<p class=MsoNormal><span lang=EN-US>The signs of SBP can be very subtle and
therefore it should be considered a possibility in all patients with ascites
due to portal hypertension.</span></p>
<p class=MsoNormal><span lang=EN-US>Ascitic fluid should be aspirated and sent
for immediate fluid albumin and microscopy including cell count. If plenty of
fluid is obtained – some can be used to inoculate blood culture bottles. </span></p>
<p class=MsoNormal><span lang=EN-US>SBP is considered to be present if the
granulocyte count is greater than 250 cells/mm3. It should be suspected if
there are typical clinical signs such as Temp &gt; 37.8ºC, abdominal pain or
tenderness or change in mental status.</span></p>
<p class=MsoNormal><span lang=EN-US>As soon as the samples are obtained, if
there are clinical signs of SBP, then treatment should be started. iv
ceftriaxone 1 g OD or oral ciprofloxacin 500 mg BD are both appropriate
empirical options. Most patients will recover with a 5 day course of treatment.</span></p>
<p class=MsoNormal><span lang=EN-US>If the patient is on propranolol, this
should be stopped permanently.</span></p>
<p class=MsoNormal><span lang=EN-US>When the patient has recovered, they should
be placed on antibiotic prophylaxis. The best choice is Septrin 960 mg OD.
Ciprofloxacin 500 mg OD is an alternative.</span></p>
<span class=Heading3Char><span lang=EN-US style='font-size:11.0pt'><br
clear=all style='page-break-before:always'>
</span></span>
<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt'><span
class=Heading3Char><span lang=EN-US><span style='text-decoration:none'>&nbsp;</span></span></span></p>
<p class=MsoNormal><span class=Heading3Char><span lang=EN-US>Hepatic
encephalopathy</span></span></p>
<p class=MsoNormal><span lang=EN-US>This is a common complication which can be
difficult to diagnose in its subtler forms. It is graded according to the
following table:</span></p>
<div class="tableCont">
  <table class=MsoNormalTable border=1 cellspacing=0 cellpadding=0
 style='border-collapse:collapse;border:none'>
 <tr>
  <td width=72 valign=top style='width:53.7pt;border:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal><span lang=EN-US>Grade 1</span></p>
  </td>
  <td width=331 valign=top style='width:247.9pt;border:solid windowtext 1.0pt;
  border-left:none;padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal><span lang=EN-US>Changes in behaviour, mild confusion,
  slurred speech, disordered sleep</span></p>
  </td>
 </tr>
 <tr>
  <td width=72 valign=top style='width:53.7pt;border:solid windowtext 1.0pt;
  border-top:none;padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal><span lang=EN-US>Grade 2</span></p>
  </td>
  <td width=331 valign=top style='width:247.9pt;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal><span lang=EN-US>Lethargy, moderate confusion</span></p>
  </td>
 </tr>
 <tr>
  <td width=72 valign=top style='width:53.7pt;border:solid windowtext 1.0pt;
  border-top:none;padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal><span lang=EN-US>Grade 3</span></p>
  </td>
  <td width=331 valign=top style='width:247.9pt;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal><span lang=EN-US>Marked confusion, incoherent speech,
  sleeping but rousable</span></p>
  </td>
 </tr>
 <tr>
  <td width=72 valign=top style='width:53.7pt;border:solid windowtext 1.0pt;
  border-top:none;padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal><span lang=EN-US>Grade 4</span></p>
  </td>
  <td width=331 valign=top style='width:247.9pt;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal><span lang=EN-US>Coma</span></p>
  </td>
 </tr>
</table>
</div>
<p class=MsoNormal><span lang=EN-US>&nbsp;</span></p>
<p class=MsoNormal><span lang=EN-US>It may be precipitated by GI bleeding,
infection (including SBP), low K<sup>+</sup>, renal failure, hypovolaemia,
hypoxia, sedatives, hypoglycaemia, constipation.</span></p>
<p class=MsoNormal><span lang=EN-US>Patients should be treated with lactulose,
beginning with a dose of 20 ml TDS. The dose should be increased until they
pass stools at least twice each day.</span></p>
<p class=MsoNormal><span lang=EN-US>Any potential triggers of encephalopathy
should be corrected.</span></p>
<h3><span lang=EN-US>Hepatorenal syndrome</span></h3>
<p class=MsoNormal><span lang=EN-US>This is the cause of about 15% of cases of
renal failure in chronic liver disease. It refers to renal failure arising from
falling renal perfusion as a direct effect of liver dysfunction. It has a very
poor prognosis and there is no treatment available for it in this setting.
Other causes of renal failure must therefore be excluded or treated before this
diagnosis is made.</span></p>
<p class=MsoNormal><span lang=EN-US>Consider alternative diagnoses of renal
failure such as hypovolaemia, sepsis, glomerulonephritis, or obstruction.</span></p>
<p class=MsoListParagraphCxSpFirst style='text-indent:-18.0pt'><span
lang=EN-US style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-US>Dip the urine – if there are white cells or red
cells, consider glomerulonephritis or a urinary infection with septic shock.</span></p>
<p class=MsoListParagraphCxSpMiddle style='text-indent:-18.0pt'><span
lang=EN-US style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-US>Stop any diuretics.</span></p>
<p class=MsoListParagraphCxSpMiddle style='text-indent:-18.0pt'><span
lang=EN-US style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-US>Give 1 litre of normal saline over 1-2 hours and
monitor urinary output and observations. If the renal failure is caused by
hypovolaemia, you should see an increase in urine output and improving
observations.</span></p>
<p class=MsoListParagraphCxSpMiddle style='text-indent:-18.0pt'><span
lang=EN-US style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-US>Treat any infection.</span></p>
<p class=MsoListParagraphCxSpLast style='text-indent:-18.0pt'><span lang=EN-US
style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-US>Arrange for a renal and bladder ultrasound to
exclude obstruction.</span></p>
<p class=MsoNormal><span lang=EN-US>Any patient who has no other diagnosis
identified and who has not had an improvement in their renal function with
these interventions may have hepatorenal syndrome. The diagnosis can be
confirmed if the creatinine rises by 25 or more within 48 hours or if there is
a 50% rise from baseline within 7 days. The treatment is supportive. A small
number will recover if they can be supported until their liver function
improves.</span></p>
<h3 style='margin-bottom:6.0pt'><span lang=EN-US>Hepatopulmonary syndrome</span></h3>
<p class=MsoNormal><span lang=EN-US>Diagnosed when a patient with CLD becomes
hypoxic and is found to have a hyperdynamic circulation. They may become
hypoxic only on sitting upright. </span></p>
<p class=MsoNormal><span lang=EN-US>Treat with oxygen and exclude other causes
of hypoxia. There is no specific treatment and the prognosis is very poor.</span></p>
<h3 style='margin-bottom:6.0pt'><span lang=EN-US>Ascites</span></h3>
<p class=MsoNormal><span lang=EN-US>Ascites is a very common complication of
chronic liver disease. It is usually diagnosed clinically and confirmed by
abdominal ultrasound. </span></p>
<p class=MsoNormal><span lang=EN-US>All CLD patients presenting with ascites
should have an immediate ascitic tap with samples sent for albumin, cell count
and culture.</span></p>
<p class=MsoNormal><span lang=EN-US>Calculate the serum ascites albumin
gradient (SAAG):</span></p>
<p class=MsoNormal style='text-indent:36.0pt'><span lang=EN-US>SAAG = serum
albumin – ascites albumin</span></p>
<p class=MsoNormal><span lang=EN-US>If SAAG is greater than 11, the ascites is
caused by portal hypertension – usually because of liver disease, but could be
due to heart failure or Budd-Chiari syndrome. If SAAG is less than 11, an
alternative diagnosis must be sought.</span></p>
<p class=MsoNormal><span lang=EN-US>If the cell count shows &gt; 250
granulocytes/mm<sup>3</sup>, then the patient has SBP and should be treated
accordingly.</span></p>
<p class=MsoNormal><span lang=EN-US>Ascites that is due to portal hypertension
in the context of CLD should be treated with salt restriction and diuretics.
Start with 40 mg furosemide OD and 100 mg spironolactone OD. If there is no
response after 3-5 days, the doses can be increased in the same ratio up to a
maximum of 160 mg furosemide and 400 mg spironolactone. A patient with ascites
and oedema may lose up to 2 kg/day whilst a patient with only ascites typically
loses no more than 0.75 kg/day.</span></p>
<p class=MsoNormal><span lang=EN-US>If the ascites is tense or the ascites
needs to be removed more quickly, large volume paracentesis can be undertaken.
Up to 5 litres can be removed each day without replacement with albumin or
other fluids.</span></p>
<p class=MsoNormal><b><i><span lang=EN-US>Patients who develop ascites should
not continue treatment with propranolol or an ACE inhibitor.</span></i></b></p>
<h3 style='margin-bottom:6.0pt'><span lang=EN-US>Hepatocellular carcinoma</span></h3>
<p class=MsoNormal><span lang=EN-US>In our setting, many patients do not
present with CLD until they already have a large hepatocellular carcinoma.
There is little that can be done to treat them apart from symptom control. </span></p>
<p class=MsoNormal><span lang=EN-US>Patients with CLD who present with a sudden
deterioration in liver function may have developed a HCC and should be sent for
ultrasound. If a new HCC is present, they should be referred to the liver
clinic for assessment once they have recovered from their acute decompensation.</span></p>
<p class=MsoNormal><span lang=EN-US>Patients should be treated with analgesia
according to the WHO analgesic ladder if they are in pain. Paracetamol is safe
in this setting. NSAIDs should be used with caution, but are the most effective
option for pain due to stretching of the liver capsule. Codeine and morphine
may trigger hepatic encephalopathy, but should be used if the patient’s pain is
severe and unresponsive to other options.</span></p>
<span lang=EN-US style='font-size:11.0pt;font-family:"Arial","sans-serif"'><br
clear=all style='page-break-before:always'>
</span>
<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt'><b><span
lang=EN-US style='font-size:12.0pt'>&nbsp;</span></b></p>
<h2><span lang=EN-US>Key Issues for Nursing care</span></h2>
<p class=MsoListParagraphCxSpFirst style='text-indent:-18.0pt'><span
lang=EN-US style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-US>Refer all patients with suspected liver disease
or complications to a doctor.</span></p>
<p class=MsoListParagraphCxSpMiddle style='text-indent:-18.0pt'><span
lang=EN-US style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-US>Assess need for pain control.</span></p>
<p class=MsoListParagraphCxSpMiddle style='text-indent:-18.0pt'><span
lang=EN-US style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-US>Check on frequency of bowel movements and if less
than or greater than two stools / day advise doctor to adjust lactulose dose
accordingly.</span></p>
<p class=MsoListParagraphCxSpMiddle style='text-indent:-18.0pt'><span
lang=EN-US style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-US>Ask patient if they have melaena stools.</span></p>
<p class=MsoListParagraphCxSpMiddle style='text-indent:-18.0pt'><span
lang=EN-US style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-US>Document presence of confusion and or changes in
behaviour which may be signs of evolving hepatic encephalopathy.</span></p>
<p class=MsoListParagraphCxSpMiddle style='text-indent:-18.0pt'><span
lang=EN-US style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-US>Order a low salt diet in patients with ascites.</span></p>
<p class=MsoListParagraphCxSpLast style='text-indent:-18.0pt'><span lang=EN-US
style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-US>Ensure adequate nutrition (with epap supplements
if necessary) for all patients with liver disease. </span></p>
<h2><span lang=EN-US>References</span></h2>
<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt'>Goldberg and
Chopra 2017. Cirrhosis in adults: Overview of complications, general
management, and prognosis. UpToDate Mar 2017.</span></p>
<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt'>Sanyal 2017.
General principles of the management of variceal haemorrhage. UpToDate Feb 2017</span></p>
<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt'>Runyon 2015.
Spontaneous bacterial peritonitis in adults: Diagnosis. UpToDate Aug 2015.</span></p>
<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt'>Runyon 2016.
Spontaneous bacterial peritonitis in adults: Treatment and prophylaxis.
UpToDate Jan 2016.</span></p>
<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt'>Ferenci 2015.
Hepatic encephalopathy in adults: Clinical manifestations and diagnosis. Sept
2015.</span></p>
<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt'>Fenerci 2017.
Hepatic encephalopathy in adults: Treatment. Aug 2017.</span></p>
<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt'>Runyon 2016.
Hepatorenal syndrome. UpToDate June 2016.</span></p>
<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt'>Goldberg and
Chopra 2016. Hepatopulmonary syndrome in adults: Prevalence, causes, clinical
manifestations, and diagnosis. Dec 2016.</span></p>
<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt'>Such and Runyon
2017. Ascites in adults with cirrhosis: Initial therapy. June 2017.</span></p>
<div class="tableCont">
  <table class=MsoNormalTable border=1 cellspacing=0 cellpadding=0
 style='border-collapse:collapse;border:none'>
 <tr style='height:1.0pt'>
  <td width=143 valign=bottom style='width:106.95pt;border:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt;height:1.0pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt'><b><span
  lang=EN-US>Written by:</span></b></p>
  </td>
  <td width=241 valign=bottom style='width:181.1pt;border:solid windowtext 1.0pt;
  border-left:none;padding:0cm 5.4pt 0cm 5.4pt;height:1.0pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt'><span
  lang=EN-US>Name: Amie Secka</span></p>
  </td>
  <td width=191 valign=bottom style='width:143.45pt;border:solid windowtext 1.0pt;
  border-left:none;padding:0cm 5.4pt 0cm 5.4pt;height:1.0pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt'><span
  lang=EN-US>Date: 6 June 2018</span></p>
  </td>
 </tr>
 <tr style='height:1.0pt'>
  <td width=143 valign=bottom style='width:106.95pt;border:solid windowtext 1.0pt;
  border-top:none;padding:0cm 5.4pt 0cm 5.4pt;height:1.0pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt'><b><span
  lang=EN-US>Reviewed by:</span></b></p>
  </td>
  <td width=241 valign=bottom style='width:181.1pt;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt;height:1.0pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt'><span
  lang=EN-US>Name: Karen Forrest</span></p>
  </td>
  <td width=191 valign=bottom style='width:143.45pt;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt;height:1.0pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt'><span
  lang=EN-US>Date: 14 June 2018</span></p>
  </td>
 </tr>
 <tr style='height:1.0pt'>
  <td width=143 valign=bottom style='width:106.95pt;border:solid windowtext 1.0pt;
  border-top:none;padding:0cm 5.4pt 0cm 5.4pt;height:1.0pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt'><b><span
  lang=EN-US>Version:</span></b></p>
  </td>
  <td width=241 valign=bottom style='width:181.1pt;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt;height:1.0pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt'><b><span
  lang=EN-US>Change history:</span></b></p>
  </td>
  <td width=191 valign=bottom style='width:143.45pt;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt;height:1.0pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt'><b><span
  lang=EN-US>Review due date:</span></b></p>
  </td>
 </tr>
 <tr style='height:1.0pt'>
  <td width=143 valign=bottom style='width:106.95pt;border:solid windowtext 1.0pt;
  border-top:none;padding:0cm 5.4pt 0cm 5.4pt;height:1.0pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt'><span
  lang=EN-US>1.0</span></p>
  </td>
  <td width=241 valign=bottom style='width:181.1pt;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt;height:1.0pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt'><span
  lang=EN-US>New document</span></p>
  </td>
  <td width=191 valign=bottom style='width:143.45pt;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt;height:1.0pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt'><span
  lang=EN-US>&nbsp;</span></p>
  </td>
 </tr>
 <tr style='height:1.0pt'>
  <td width=143 valign=bottom style='width:106.95pt;border:solid windowtext 1.0pt;
  border-top:none;padding:0cm 5.4pt 0cm 5.4pt;height:1.0pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt'><span
  lang=EN-US>2.0</span></p>
  </td>
  <td width=241 valign=bottom style='width:181.1pt;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt;height:1.0pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt'><span
  lang=EN-US>Adapted from previous guideline on CLD and format updated.</span></p>
  </td>
  <td width=191 valign=bottom style='width:143.45pt;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt;height:1.0pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt'><span
  lang=EN-US>31 July 2020</span></p>
  </td>
 </tr>
 <tr style='height:1.0pt'>
  <td width=143 valign=bottom style='width:106.95pt;border:solid windowtext 1.0pt;
  border-top:none;padding:0cm 5.4pt 0cm 5.4pt;height:1.0pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt'><span
  lang=EN-US>Review Comments (<i>if applicable)</i></span></p>
  </td>
  <td width=241 valign=bottom style='width:181.1pt;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt;height:1.0pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt'><span
  lang=EN-US>&nbsp;</span></p>
  </td>
  <td width=191 valign=bottom style='width:143.45pt;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt;height:1.0pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt'><b><span
  lang=EN-US>&nbsp;</span></b></p>
  </td>
 </tr>
</table>
</div>
<p class=MsoNormal><span lang=EN-US>&nbsp;</span></p>
<p class=MsoNormal><span lang=EN-US>&nbsp;</span></p>
</div>
</div><!-- /content -->
<div data-role="panel" data-position="right" data-display="overlay" data-position-fixed="true" data-theme="b" id="leftpanel1">
	<a href="#" data-rel="close" data-theme="b" class="ui-btn ui-corner-all ui-shadow ui-btn-a ui-icon-delete ui-btn-icon-notext ui-btn-right">Close</a>
  <h1>About this app</h1>
  <div>
    This app is designed to provide doctors and nurses with quick access to the clinical guidelines of the Clinical Services Department of the MRC Unit The Gambia at LSHTM. <br>Users will be notified of updates via departmental email. <br>For feedback or support, email fakemokwe@mrc.gm
  </div>
</div>
</div>
<div data-role="footer" data-tap-toggle="false" data-id="persistent-footer" data-position="fixed" data-theme="a">
  <a href="index.html" class="ui-btn ui-corner-all ui-btn-inline ui-mini footer-button-left ui-btn-icon-left ui-icon-home">Home</a>
  <a href="#" onclick="topFunction()" id="myBtn" class="ui-btn ui-corner-all ui-btn-inline ui-mini footer-button-right ui-btn-icon-right ui-icon-carat-u">Top</a>  
</div>
</body>
</html>
